News | July 24, 2025
Dr Reddy's Laboratories reports 2% rise in Q1 net profit to Rs. 1,418 Cr
Revenue increased 11.4 per cent to Rs. 8,545 crore
Revenue increased 11.4 per cent to Rs. 8,545 crore
FDA requests Sarepta Therapeutics to suspend distribution of Elevidys and places clinical trials on hold for multiple gene therapy products following 3 deaths
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
The FDA set a target action date of April 28, 2026, under the Prescription Drug User Fee Act
Now approved for both acute and chronic HCV in adults and children aged 3 and above
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Asahi Kasei Life Science covers a broad range of bioprocess products and services
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Subscribe To Our Newsletter & Stay Updated
